The combined effect of CO 2 laser, topical diclofenac 3%, and imiquimod 5% in treating high‐risk basal cell carcinoma

2021 ◽  
Author(s):  
Mohamed El‐Khalawany ◽  
Wael M. Saudi ◽  
Eman Ahmed ◽  
Alsadat Mosbeh ◽  
Ahmed Sameh ◽  
...  
Keyword(s):  
High Risk ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Combined Effect ◽  
Topical Diclofenac

scholarly journals Evaluation of Patched-1 Protein Expression Level in Low Risk and High Risk Basal Cell Carcinoma Subtypes

2019 ◽  
Vol 20 (9) ◽  
pp. 2851-2857 ◽  
Author(s):  
Rowida Almomani ◽  
Mariam Khanfar ◽  
Khaldon Bodoor ◽  
Firas Al-Qarqaz ◽  
Mohammad Alqudah ◽  
...  
Keyword(s):  
High Risk ◽  
Basal Cell Carcinoma ◽  
Protein Expression ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Low Risk ◽  
Expression Level ◽  
Protein Expression Level ◽  
Patched 1

Classification of high risk basal cell carcinoma subtypes: experience of the ONTRAC study with proposed definitions and guidelines for pathological reporting

Pathology ◽  
2016 ◽  
Vol 48 (5) ◽  
pp. 395-397 ◽  
Author(s):  
Catriona A. McKenzie ◽  
Andrew C. Chen ◽  
Bonita Choy ◽  
Pablo Fernández-Peñas ◽  
Diona L. Damian ◽  
...  
Keyword(s):  
High Risk ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell

scholarly journals Metastatic basal cell carcinoma with evidence of intravascular invasion: A case report

2020 ◽  
Vol 8 ◽  
pp. 2050313X1984778
Author(s):  
Lindsey West ◽  
Ramin Fathi ◽  
Rajiv Nijhawan ◽  
Divya Srivastava
Keyword(s):  
High Risk ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
High Risk Factors ◽  
Positron Emission ◽  
Metastatic Basal Cell Carcinoma ◽  
Cervical Level ◽  
Tomography Scan ◽  
Common Malignancy

Although basal cell carcinoma is the most common malignancy in humans, intravascular basal cell carcinoma is rarely reported in the literature. A 78-year-old male presented for Mohs Micrographic surgery of a 1.5 by 1.5 cm2 nodular and focally infiltrative basal cell carcinoma on the left parietal scalp. In the fifth stage, intravascular tumor cells were noted, and the patient was still positive in five out of six specimens with a defect measuring 6.5 × 7.0 cm2. Mohs surgery was stopped due to concern of widespread disease. A positron emission tomography/computed tomography scan was ordered that demonstrated diffuse prominent activity in the cervical level IIa nodes, right sacrum, right scapula, and the third left rib, concerning for metastatic disease. This case emphasizes the importance of vigilance to examine high-risk basal cell carcinoma pathology for intravascular invasion in addition to perineural invasion, especially in the setting of high risk factors for metastatic basal cell carcinoma.

An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma

2014 ◽  
Vol 71 (5) ◽  
pp. 904-911.e1 ◽  
Author(s):  
Mina Sarah Ally ◽  
Sumaira Aasi ◽  
Ashley Wysong ◽  
Claudia Teng ◽  
Eric Anderson ◽  
...  
Keyword(s):  
Clinical Trial ◽  
High Risk ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Open Label

scholarly journals Predictors of Basal Cell Carcinoma in High-Risk Patients in the VATTC (VA Topical Tretinoin Chemoprevention) Trial

2012 ◽  
Vol 132 (11) ◽  
pp. 2544-2551 ◽  
Author(s):  
Robert K. Dyer ◽  
Martin A. Weinstock ◽  
Tobias S.D. Cohen ◽  
Amilcar E. Rizzo ◽  
Stephen F. Bingham ◽  
...  
Keyword(s):  
High Risk ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Topical Tretinoin ◽  
High Risk Patients ◽  
Risk Patients ◽  
Chemoprevention Trial
Sign in / Sign up

Export Citation Format

Share Document